Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Pharmaceutical Investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Pharmaceutical Investing VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
Pharmaceutical Investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
Pharmaceutical Investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
Skyharbour's Partner North Shore Uranium Signs Exploration Agreement with English Rivers First Nation
NorthStar Gaming Launches Spring Tournament Series with Up To $100,000 Prize Pool on Slots, Parlay and Blackjack Tournaments
Global Uranium and Forum Energy Metals Announce the Commencement of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan
